{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:04:07Z","timestamp":1791259447129,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2013.29","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T13:39:28Z","timestamp":1367329168000},"page":"e252-e252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions"],"prefix":"10.1038","volume":"3","author":[{"given":"M","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sotoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Namba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Iwakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"key":"BFtp201329_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.mp.4001081","volume":"7","author":"T Futamura","year":"2002","unstructured":"Futamura T, Toyooka K, Iritani S, Niizato K, Nakamura R, Tsuchiya K et al. Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol Psychiatry 2002; 7: 673\u2013682.","journal-title":"Mol Psychiatry"},{"key":"BFtp201329_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1086\/342734","volume":"71","author":"H Stefansson","year":"2002","unstructured":"Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877\u2013892.","journal-title":"Am J Hum Genet"},{"key":"BFtp201329_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00001756-199412300-00028","volume":"6","author":"KB Seroogy","year":"1994","unstructured":"Seroogy KB, Numan S, Gall CM, Lee DC, Kornblum HI . Expression of EGF receptor mRNA in rat nigrostriatal system. Neuroreport 1994; 6: 105\u2013108.","journal-title":"Neuroreport"},{"key":"BFtp201329_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1006\/exnr.1999.7163","volume":"159","author":"H Steiner","year":"1999","unstructured":"Steiner H, Blum M, Kitai ST, Fedi P . Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp Neurol 1999; 159: 494\u2013503.","journal-title":"Exp Neurol"},{"key":"BFtp201329_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroscience.2009.03.022","volume":"161","author":"Y Abe","year":"2009","unstructured":"Abe Y, Namba H, Zheng Y, Nawa H . In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 2009; 161: 95\u2013110.","journal-title":"Neuroscience"},{"key":"BFtp201329_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.mp.4001138","volume":"8","author":"T Futamura","year":"2003","unstructured":"Futamura T, Kakita A, Tohmi M, Sotoyama H, Takahashi H, Nawa H . Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development. Mol Psychiatry 2003; 8: 19\u201329.","journal-title":"Mol Psychiatry"},{"key":"BFtp201329_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2004.08.066","volume":"1028","author":"DM Yurek","year":"2004","unstructured":"Yurek DM, Zhang L, Fletcher-Turner A, Seroogy KB . Supranigral injection of neuregulin1-beta induces striatal dopamine overflow. Brain Res 2004; 1028: 116\u2013119.","journal-title":"Brain Res"},{"key":"BFtp201329_CR8","doi-asserted-by":"publisher","first-page":"10116","DOI":"10.1523\/JNEUROSCI.2368-07.2007","volume":"27","author":"M Mizuno","year":"2007","unstructured":"Mizuno M, Sotoyama H, Narita E, Kawamura H, Namba H, Zheng Y et al. A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor. J Neurosci 2007; 27: 10116\u201310127.","journal-title":"J Neurosci"},{"key":"BFtp201329_CR9","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02817.x","volume":"91","author":"L Zhang","year":"2004","unstructured":"Zhang L, Fletcher-Turner A, Marchionni MA, Apparsundaram S, Lundgren KH, Yurek DM et al. Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures. J Neurochem 2004; 91: 1358\u20131368.","journal-title":"J Neurochem"},{"issue":"Part 1","key":"BFtp201329_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1471-4159.2011.07287.x","volume":"118","author":"Y Iwakura","year":"2011","unstructured":"Iwakura Y, Zheng Y, Sibilia M, Abe Y, Piao YS, Yokomaku D et al. Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1) J Neurochem 2011; 118: 45\u201356.","journal-title":"J Neurochem"},{"key":"BFtp201329_CR11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1471-4159.2011.07284.x","volume":"117","author":"T Carlsson","year":"2011","unstructured":"Carlsson T, Schindler FR, H\u00f6llerhage M, Depboylu C, Arias-Carri\u00f3n O, Schnurrbusch S et al. Systemic administration of neuregulin-1\u03b21 protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J Neurochem 2011; 117: 1066\u20131074.","journal-title":"J Neurochem"},{"key":"BFtp201329_CR12","doi-asserted-by":"publisher","first-page":"15587","DOI":"10.1073\/pnas.0805722105","volume":"105","author":"OB Kwon","year":"2008","unstructured":"Kwon OB, Paredes D, Gonzalez CM, Neddens J, Hernandez L, Vullhorst D et al. Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. Proc Natl Acad Sci USA 2008; 105: 15587\u201315592.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp201329_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pnpbp.2008.12.010","volume":"33","author":"K Tomiyama","year":"2009","unstructured":"Tomiyama K, O'Tuathaigh CM, O'Sullivan GJ, Kinsella A, Lai D, Harvey RP et al. Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' mice. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 330\u2013333.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp201329_CR14","doi-asserted-by":"publisher","first-page":"e14185","DOI":"10.1371\/journal.pone.0014185","volume":"5","author":"T Kato","year":"2010","unstructured":"Kato T, Kasai A, Mizuno M, Fengyi L, Shintani N, Maeda S et al. Phenotypic characterization of transgenic mice overexpressing neuregulin-1. PLoS ONE 2010; 5: e14185.","journal-title":"PLoS ONE"},{"key":"BFtp201329_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/mp.2010.10","volume":"16","author":"T Kato","year":"2011","unstructured":"Kato T, Abe Y, Sotoyama H, Kakita A, Kominami R, Hirokawa S et al. Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. Mol Psy 2011; 16: 307\u2013320.","journal-title":"Mol Psy"},{"key":"BFtp201329_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.biopsych.2005.11.002","volume":"60","author":"PJ Harrison","year":"2006","unstructured":"Harrison PJ, Law AJ . Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006; 60: 132\u2013140.","journal-title":"Biol Psychiatry"},{"key":"BFtp201329_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrn2392","volume":"9","author":"L Mei","year":"2008","unstructured":"Mei L, Xiong WC . Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008; 9: 437\u2013452.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201329_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.neures.2006.06.002","volume":"56","author":"H Nawa","year":"2006","unstructured":"Nawa H, Takei N . Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 2006; 56: 2\u201313.","journal-title":"Neurosci Res"},{"key":"BFtp201329_CR19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1017\/S1461145711001404","volume":"15","author":"A Pereira","year":"2012","unstructured":"Pereira A, Sugiharto-Winarno A, Zhang B, Malcolm P, Fink G, Sundram S . Clozapine induction of ERK1\/2 cell signalling via the EGF receptor in mouse prefrontal cortex and striatum is distinct from other antipsychotic drugs. Int J Neuropsychopharmacol 2012; 15: 1149\u20131160.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Part 2","key":"BFtp201329_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1471-4159.2011.07295.x","volume":"18","author":"Y Iwakura","year":"2011","unstructured":"Iwakura Y, Wang R, Abe Y, Piao YS, Shishido Y, Higashiyama S et al. Dopamine-dependent ectodomain shedding and release of epidermal growth factor in developing striatum: target-derived neurotrophic signaling (Part 2) J Neurochem 2011; 18: 57\u201368.","journal-title":"J Neurochem"},{"key":"BFtp201329_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1471-4159.2005.03073.x","volume":"93","author":"Y Iwakura","year":"2005","unstructured":"Iwakura Y, Piao YS, Mizuno M, Takei N, Kakita A, Takahashi H et al. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. J Neurochem 2005; 93: 974\u2013983.","journal-title":"J Neurochem"},{"key":"BFtp201329_CR22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ajmg.b.30275","volume":"141B","author":"G Silberberg","year":"2006","unstructured":"Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R . The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 142\u2013148.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFtp201329_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fncel.2013.00004","volume":"7","author":"Y Iwakura","year":"2013","unstructured":"Iwakura Y, Nawa H . ErbB1-4-dependent EGF\/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease. Front Cell Neurosci 2013; 7: 4.","journal-title":"Front Cell Neurosci"},{"key":"BFtp201329_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1254\/jphs.10099FP","volume":"114","author":"M Mizuno","year":"2010","unstructured":"Mizuno M, Iwakura Y, Shibuya M, Zheng Y, Eda T, Kato T et al. Antipsychotic potential of quinazoline ErbB1 inhibitors in a schizophrenia model established with neonatal hippocampal lesioning. J Pharmacol Sci 2010; 114: 320\u2013331.","journal-title":"J Pharmacol Sci"},{"key":"BFtp201329_CR25","unstructured":"Nawa H, Mizuno M Antipsychotic molecular-targeting epithelial growth factor receptor. United States Patent Application 20060167026."},{"key":"BFtp201329_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0306-4522(01)00384-0","volume":"107","author":"C Wang","year":"2001","unstructured":"Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, Johnson KM . Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 2001; 107: 535\u2013550.","journal-title":"Neuroscience"},{"key":"BFtp201329_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10519-005-5357-7","volume":"35","author":"M Tohmi","year":"2005","unstructured":"Tohmi M, Tsuda N, Mizuno M, Takei N, Frankland PW, Nawa H . Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strains. Behav Genet 2005; 35: 615\u2013629.","journal-title":"Behav Genet"},{"key":"BFtp201329_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1021\/jm9503613","volume":"39","author":"AJ Bridges","year":"1996","unstructured":"Bridges AJ, Zhou H, Cody DR, Rewcastle GW, McMichael A, Showalter HD et al. Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J Med Chem 1996; 39: 267\u2013276.","journal-title":"J Med Chem"},{"key":"BFtp201329_CR29","first-page":"8887","volume":"61","author":"SL Moulder","year":"2001","unstructured":"Moulder SL, Yakes FM, Muthuswamy SK, Bianco R, Simpson JF, Arteaga CL . Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2\/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. Cancer Res 2001; 61: 8887\u20138895.","journal-title":"Cancer Res"},{"key":"BFtp201329_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3346\/jkms.2007.22.2.290","volume":"22","author":"GT Park","year":"2007","unstructured":"Park GT, Kim HY, Kim EK, Yang JM . Autocrine extracellular signal-regulated kinase activation in normal human keratinocytes is not interrupted by calcium triggering and is involved in the control of cell cycle at the early stage of calcium-induced differentiation. J Korean Med Sci 2007; 22: 290\u2013297.","journal-title":"J Korean Med Sci"},{"key":"BFtp201329_CR31","doi-asserted-by":"publisher","first-page":"26340","DOI":"10.1074\/jbc.M109.023010","volume":"284","author":"N Takei","year":"2009","unstructured":"Takei N, Kawamura M, Ishizuka Y, Kakiya N, Inamura N, Namba H et al. Brain-derived neurotrophic factor enhances the basal rate of protein synthesis by increasing active eukaryotic elongation factor 2 levels and promoting translation elongation in cortical neurons. J Biol Chem 2009; 284: 26340\u201326348.","journal-title":"J Biol Chem"},{"key":"BFtp201329_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00008877-200006000-00002","volume":"11","author":"NR Swerdlow","year":"2000","unstructured":"Swerdlow NR, Braff DL, Geyer MA . Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 2000; 11: 185\u2013204.","journal-title":"Behav Pharmacol"},{"key":"BFtp201329_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bbr.2004.02.016","volume":"154","author":"WN Zhang","year":"2004","unstructured":"Zhang WN, Murphy CA, Feldon J . Behavioural and cardiovascular responses during latent inhibition of conditioned fear: measurement by telemetry and conditioned freezing. Behav Brain Res 2004; 154: 199\u2013209.","journal-title":"Behav Brain Res"},{"key":"BFtp201329_CR34","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.neuron.2006.05.007","volume":"50","author":"M Mameli-Engvall","year":"2006","unstructured":"Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux JP et al. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 2006; 50: 911\u2013921.","journal-title":"Neuron"},{"key":"BFtp201329_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2012.02.003","volume":"35","author":"MA Ungless","year":"2012","unstructured":"Ungless MA, Grace AA . Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci 2012; 35: 422\u2013430.","journal-title":"Trends Neurosci"},{"key":"BFtp201329_CR36","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1523\/JNEUROSCI.04-11-02877.1984","volume":"4","author":"AA Grace","year":"1984","unstructured":"Grace AA, Bunney BS . The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 1984; 4: 2877\u20132890.","journal-title":"J Neurosci"},{"key":"BFtp201329_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.braindev.2008.01.006","volume":"30","author":"N Tsuda","year":"2008","unstructured":"Tsuda N, Mizuno M, Yamanaka T, Komurasaki T, Yoshimoto M, Nawa H . Common behavioral influences of the ErbB1 ligands transforming growth factor alpha and epiregulin administered to mouse neonates. Brain Dev 2008; 30: 533\u2013543.","journal-title":"Brain Dev"},{"key":"BFtp201329_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1196\/annals.1316.076","volume":"1025","author":"M Mizuno","year":"2004","unstructured":"Mizuno M, Malta RS Jr, Nagano T, Nawa H . Conditioned place preference and locomotor sensitization after repeated administration of cocaine or methamphetamine in rats treated with epidermal growth factor during the neonatal period. Ann NY Acad Sci 2004; 1025: 612\u2013618.","journal-title":"Ann NY Acad Sci"},{"key":"BFtp201329_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00702-007-0867-5","volume":"115","author":"M Mizuno","year":"2008","unstructured":"Mizuno M, Kawamura H, Takei N, Nawa H . The anthraquinone derivative emodin ameliorates neurobehavioral deficits of a rodent model for schizophrenia. J Neural Transm 2008; 115: 521\u2013530.","journal-title":"J Neural Transm"},{"key":"BFtp201329_CR40","first-page":"3","volume":"15","author":"DW Fry","year":"2000","unstructured":"Fry DW . Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer. Anticancer Drug Des 2000; 15: 3\u201316.","journal-title":"Anticancer Drug Des"},{"key":"BFtp201329_CR41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1470-2045(03)01137-9","volume":"4","author":"SS Sridhar","year":"2003","unstructured":"Sridhar SS, Seymour L, Shepherd FA . Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer. Lancet Oncol 2003; 4: 397\u2013406.","journal-title":"Lancet Oncol"},{"key":"BFtp201329_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1158\/1535-7163.MCT-04-0329","volume":"4","author":"D McKillop","year":"2005","unstructured":"McKillop D, Partridge EA, Kemp JV, Spence MP, Kendrew J, Barnett S et al. Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor. Mol Cancer Ther 2005; 4: 641\u2013649.","journal-title":"Mol Cancer Ther"},{"key":"BFtp201329_CR43","doi-asserted-by":"publisher","first-page":"e25831","DOI":"10.1371\/journal.pone.0025831","volume":"6","author":"H Sotoyama","year":"2011","unstructured":"Sotoyama H, Zheng Y, Iwakura Y, Mizuno M, Aizawa M, Shcherbakova K et al. Pallidal hyperdopaminergic innervation underlying D2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF. PLoS ONE 2011; 6: e25831.","journal-title":"PLoS ONE"},{"key":"BFtp201329_CR44","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbr.2009.05.004","volume":"204","author":"I Weiner","year":"2009","unstructured":"Weiner I, Arad M . Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behav Brain Res 2009; 204: 369\u2013386.","journal-title":"Behav Brain Res"},{"key":"BFtp201329_CR45","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1037\/0735-7044.109.5.912","volume":"109","author":"MH Kodsi","year":"1995","unstructured":"Kodsi MH, Swerdlow NR . Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behav Neurosci 1995; 109: 912\u2013928.","journal-title":"Behav Neurosci"},{"key":"BFtp201329_CR46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00213-006-0595-9","volume":"191","author":"H Sotoyama","year":"2007","unstructured":"Sotoyama H, Namba H, Takei N, Nawa H . Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating. Psychopharmacology (Berl) 2007; 191: 783\u2013792.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201329_CR47","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1038\/npp.2008.41","volume":"33","author":"S Arai","year":"2008","unstructured":"Arai S, Takuma K, Mizoguchi H, Ibi D, Nagai T, Takahashi K et al. Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen. Neuropsychopharmacology 2008; 33: 3164\u20133175.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201329_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrn2054","volume":"8","author":"S Bauer","year":"2007","unstructured":"Bauer S, Kerr BJ, Patterson PH . The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 2007; 8: 221\u2013232.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201329_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neuron.2006.09.023","volume":"52","author":"PA Arguello","year":"2006","unstructured":"Arguello PA, Gogos JA . Modeling madness in mice: one piece at a time. Neuron 2006; 52: 179\u2013196.","journal-title":"Neuron"},{"key":"BFtp201329_CR50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00213-009-1504-9","volume":"206","author":"U Meyer","year":"2009","unstructured":"Meyer U, Feldon J . Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology (Berl) 2009; 206: 587\u2013602.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201329_CR51","doi-asserted-by":"crossref","unstructured":"Sotoyama H, Namba H, Chiken S, Nambu A, Nawa H . Abnormal hyperactivity of pallidal GABA neurons in the schizophrenia animal model established by the cytokine EGF exposure. J Neurochem 2013 doi:10.1111\/jnc.12223.","DOI":"10.1111\/jnc.12223"},{"key":"BFtp201329_CR52","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/schbul\/sbp049","volume":"35","author":"PD Morrison","year":"2009","unstructured":"Morrison PD, Murray RM . From real-world events to psychosis: the emerging neuropharmacology of delusions. Schizophr Bull 2009; 35: 668\u2013674.","journal-title":"Schizophr Bull"},{"key":"BFtp201329_CR53","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.pnpbp.2011.04.002","volume":"35","author":"B Pan","year":"2011","unstructured":"Pan B, Huang XF, Deng C . Antipsychotic treatment and neuregulin-1-ErbB4 signalling in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatr 2011; 35: 924\u2013930.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"BFtp201329_CR54","first-page":"553","volume":"11","author":"XD Wang","year":"2008","unstructured":"Wang XD, Su YA, Guo CM, Yang Y, Si TM . Chronic antipsychotic drug administration alters the expression of neuregulin 1b, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus. Int J Neuropsychopharmacol 2008; 11: 553\u2013556.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl.1","key":"BFtp201329_CR55","first-page":"A49","volume":"44","author":"B Pan","year":"2010","unstructured":"Pan B, Huang XF, Hu CH, Han M, Deng C . Effects of typical and atypical antipsychotics on the expressions of neuregulin 1 and ErbB4 receptors. Aust New Zealand J Psychiatry 2010; 44 (Suppl.1): A49.","journal-title":"Aust New Zealand J Psychiatry"},{"key":"BFtp201329_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12031-009-9188-5","volume":"39","author":"A Pereira","year":"2009","unstructured":"Pereira A, Fink G, Sundram S . Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor. J Mol Neurosci 2009; 39: 185\u2013198.","journal-title":"J Mol Neurosci"},{"key":"BFtp201329_CR57","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0014-2999(83)90506-X","volume":"89","author":"E Melamed","year":"1983","unstructured":"Melamed E, Durst R, Frucht Y, Globus M . Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons. Eur J Pharmacol 1983; 89: 279\u2013282.","journal-title":"Eur J Pharmacol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tp201329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tp201329","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:59:41Z","timestamp":1672955981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp201329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4]]}},"alternative-id":["BFtp201329"],"URL":"https:\/\/doi.org\/10.1038\/tp.2013.29","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]},"assertion":[{"value":"24 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Higeta Shoyu Co., Ltd., provided recombinant EGF for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}